Thursday, October 27, 2022
Panoramic Health℠, the nation’s leading integrated value-based kidney care platform, announced the launch of its clinical research division dedicated to advancing kidney care innovation and improving patient outcomes.
The new division, branded as Panoramic Science, will drive the discovery of cutting-edge treatments for patients with kidney disease.
“Panoramic Health improves patient outcomes through its superior platform fueled by data and analytics, nephrology practices nationwide, and value-based care solutions, which will now spearhead clinical research innovation,” said Rajiv Poduval, M.D., FASN, CEO and co-founder of Panoramic Health. “As the largest integrated value-based kidney care platform developing new, research-driven kidney-care solutions, we are deepening our pledge to enhance quality of life for patients.”
Uniquely positioned to remove barriers to kidney care clinical trials, Panoramic Health’s clinical research division provides access to large, representative patient populations and a national platform of Principal Investigators at trial-ready sites including ambulatory surgery centers.
Partnering with independent researchers, pharmaceutical companies, medical device companies, and clinical research organizations, Panoramic Health will conduct research with more than 800 providers across 19 states, leveraging the largest real-time patient database of more than 630,000 CKD-ESKD patients.
“Clinical research is an exciting step forward for Panoramic Health,” said Nick Carlucci, Senior VP of Growth Operations and Ancillary Services. “This launch is proof that we deliver on our commitment to advance kidney disease therapies to serve patients, physician partners, and the overall kidney care ecosystem.”
Panoramic Health assembled a clinical research leadership team with extensive expertise in clinical trial management including the regulatory and start-up process, budget and contracting, compliance, site training, and protocol implementation.
